Added to Your Shopping Cart
Certificate of Analysis
Are you looking for...
You might be interested in...
Type in Product name, Keyword or Catalog number to see suggestions.
Need help? Please contact us
Pharma & Biotech
Save to list
Save to list
Accelerating Time to Market for CAR-T Cell Therapies through Translatable Workflow
1
of
Only registered User can view this video. Please login or create an account.
Watch this 60-min roundtable discussion and join our expert panel as they discuss challenges, promising tools, trends and the future of CAR-T therapies.
Don't have time to watch the full webinar? Just click the blue arrow next to the video and access the written summary.
Topics include:
- Key considerations for advancing CAR/TCR therapies to the clinic and commercialization
- Major pain points in CAR-T processes that need further development
- Advantages and challenges of closed system transduction/transfection platforms
- Selecting raw materials and GMP ancillary choices
- The future of CRISPR/CAS based systems
Panelists:
- Isabelle Rivière
Director, Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center - Metin Kurtoglu
Chief GMP Manufacturing and Chief Medical Officer, Cartesian Therapeutics - Tariq Haq
Head of Cell and Gene Therapy Segment Marketing at Lonza Bioscience Solutions
This event has been produced in collaboration with BioInsights.
Would you like to learn more about Lonza’s integrated, scalable solutions for CAR-T and cell and gene therapy development and manufacturing?
Would you like to receive updates? Subscribe to our cell and gene therapy eNews to stay tuned on new educational content or product and applications news.